Dr. Wenhui Hu obtained a Ph.D. from Peking Union Medical College (PUMC) in 1996. In 1999, he embarked on a new chapter in the USA, joining Dr. Hongbing Shu’s Lab as a postdoctoral fellow at the National Jewish Medical Center, the University of Colorado. He spent the years 2000 to 2004 as a postdoctoral fellow, eventually attaining the position of Assistant Scientist in the Miami Project to Cure Paralysis, the University of Miami. His academic achievements culminated in achieving tenure as an Associate Professor in 2013 and subsequently becoming a Full Professor of Neuroscience and Pathology in 2021. He returned to the VCU as a Full Professor in the Department of Anatomy and Neurobiology in 2023. His research in the USA has been multifaceted, focusing on gene regulation (NIBP, TCF4, and RGS4), signal transduction (NFkB and G protein signaling), and novel biotechnology (siRNA, Cas9, and iPS). His lentivirus-like particle technology earned the NIH TARGETED Challenge Prize
(Phase I) in 2023. With a prolific publication record of over 120 papers in high-impact journals and holding six patents, his contributions extend to licensing agreements with biotech companies for clinical trials and commercialization.
Jian Zhu is a Professor (with Tenure) at the Department of Pathology, the Ohio State University Wexner Medical Center, Columbus, OH, USA. He completed his Ph.D. at the Johns Hopkins University School of Medicine. Then, he worked as a postdoc fellow at the Brigham and Women’s Hospital at Harvard Medical School. From 2013 to 2018, he was an Assistant Professor at the University of Rochester Medical Center, USA. He works at the interface between virology, immunology, genetics, and cellular and molecular biology.
